Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | REGISTRATION STATEMENT | ea0205761-03.htm | S-1 | 5683916 |
| 2 | FORM OF UNDERWRITING AGREEMENT | ea020576103ex1-1_osthera.htm | EX-1.1 | 249665 |
| 3 | THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF OS THERAPIES INCORPOR | ea020576103ex3-1_osthera.htm | EX-3.1 | 55926 |
| 4 | FORM OF CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE O | ea020576103ex3-2_osthera.htm | EX-3.2 | 11272 |
| 5 | AMENDED AND RESTATED BYLAWS OF OS THERAPIES INCORPORATED | ea020576103ex3-3_osthera.htm | EX-3.3 | 126328 |
| 6 | SPECIMEN COMMON STOCK CERTIFICATE | ea020576103ex4-1_osthera.htm | EX-4.1 | 8512 |
| 7 | FORM OF REPRESENTATIVE'S WARRANT | ea020576103ex4-2_osthera.htm | EX-4.2 | 76937 |
| 8 | FORM OF PLACEMENT AGENT WARRANT (GROUP B CONVERTIBLE NOTES PLACEMENT) | ea020576103ex4-3_osthera.htm | EX-4.3 | 103431 |
| 9 | FORM OF PLACEMENT AGENT WARRANT (GROUP C CONVERTIBLE NOTES PLACEMENT) | ea020576103ex4-4_osthera.htm | EX-4.4 | 99609 |
| 10 | FORM OF PLACEMENT AGENT WARRANT (GROUP D CONVERTIBLE NOTES PLACEMENT) | ea020576103ex4-5_osthera.htm | EX-4.5 | 100869 |
| 11 | OPINION OF OLSHAN FROME WOLOSKY LLP, AS TO THE LEGALITY OF THE COMMON STOCK | ea020576103ex5-1_osthera.htm | EX-5.1 | 10846 |
| 12 | FORM OF GROUP A CONVERTIBLE NOTE | ea020576103ex10-1_osthera.htm | EX-10.1 | 35222 |
| 13 | FORM OF GROUP B CONVERTIBLE NOTE | ea020576103ex10-2_osthera.htm | EX-10.2 | 118798 |
| 14 | FORM OF GROUP C CONVERTIBLE NOTE | ea020576103ex10-3_osthera.htm | EX-10.3 | 114345 |
| 15 | FORM OF GROUPS D, E AND F CONVERTIBLE NOTE | ea020576103ex10-4_osthera.htm | EX-10.4 | 118016 |
| 16 | AMENDED AND RESTATED DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT, DATED AS OF NOVE | ea020576103ex10-5_osthera.htm | EX-10.5 | 241863 |
| 17 | FIRST AMENDMENT TO AMENDED AND RESTATED DEVELOPMENT, LICENSE AND SUPPLY AGREEMEN | ea020576103ex10-5i_osthera.htm | EX-10.5(I) | 17216 |
| 18 | LICENSE AGREEMENT, DATED AS OF AUGUST 19, 2020, BY AND BETWEEN OS THERAPIES INCO | ea020576103ex10-6_osthera.htm | EX-10.6 | 160989 |
| 19 | EMPLOYMENT AGREEMENT, DATED AS OF FEBRUARY 21, 2023, BETWEEN OS THERAPIES INCORP | ea020576103ex10-7_osthera.htm | EX-10.7 | 38400 |
| 20 | EMPLOYMENT LETTER, DATED JUNE 23, 2020, BETWEEN OS THERAPIES INCORPORATED AND RO | ea020576103ex10-8_osthera.htm | EX-10.8 | 42114 |
| 21 | FORM OF INDEMNIFICATION AGREEMENT BETWEEN OS THERAPIES INCORPORATED AND EACH OF | ea020576103ex10-10_osthera.htm | EX-10.10 | 84304 |
| 22 | OS THERAPIES INCORPORATED 2023 INCENTIVE COMPENSATION PLAN | ea020576103ex10-11_osthera.htm | EX-10.11 | 128479 |
| 23 | FORM OF FIRST AMENDMENT TO THE OS THERAPIES INCORPORATED 2023 INCENTIVE COMPENSA | ea020576103ex10-11i_osthera.htm | EX-10.11(I) | 7283 |
| 24 | EMPLOYMENT LETTER, DATED JANUARY 1, 2023, BETWEEN OS THERAPIES INCORPORATED AND | ea020576103ex10-12_osthera.htm | EX-10.12 | 31522 |
| 25 | CONSENT OF MALONEBAILEY, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea020576103ex23-1_osthera.htm | EX-23.1 | 2667 |
| 26 | CALCULATION OF FILING FEE TABLE | ea020576103ex-fee_osthera.htm | EX-FILING FEES | 38230 |
| 27 | GRAPHIC | tos_logo.jpg | GRAPHIC | 85271 |
| 28 | GRAPHIC | timage_001.jpg | GRAPHIC | 331818 |
| 29 | GRAPHIC | timage_002.jpg | GRAPHIC | 340811 |
| 30 | GRAPHIC | tflowchart_001.jpg | GRAPHIC | 324455 |
| 31 | GRAPHIC | ex5-1_001.jpg | GRAPHIC | 15088 |
| 32 | GRAPHIC | ex5-1_002.jpg | GRAPHIC | 10751 |
| 33 | GRAPHIC | ex10-7_001.jpg | GRAPHIC | 3800 |
| 34 | GRAPHIC | ex10-8_001.jpg | GRAPHIC | 4875 |
| 35 | GRAPHIC | ex10-12_001.jpg | GRAPHIC | 2018 |
| 36 | GRAPHIC | ex23-1_001.jpg | GRAPHIC | 21293 |
| 37 | GRAPHIC | ex23-1_002.jpg | GRAPHIC | 67674 |
| Complete submission text file | 0001213900-24-048049.txt | 9373103 |
IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-279839 | Film No.: 241006494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
